{"id":"https://openalex.org/W2102298517","doi":"https://doi.org/10.2174/1389450111314050007","title":"Serotonergic Drugs for Depression and Beyond","display_name":"Serotonergic Drugs for Depression and Beyond","publication_year":2013,"publication_date":"2013-04-01","ids":{"openalex":"https://openalex.org/W2102298517","doi":"https://doi.org/10.2174/1389450111314050007","mag":"2102298517","pmid":"https://pubmed.ncbi.nlm.nih.gov/23531115"},"language":"en","primary_location":{"id":"doi:10.2174/1389450111314050007","doi":"https://doi.org/10.2174/1389450111314050007","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1389450111314050007","pdf_url":null,"source":{"id":"https://openalex.org/S140884253","display_name":"Current Drug Targets","issn_l":"1389-4501","issn":["1389-4501","1873-5592"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Targets","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015501263","display_name":"Stephen M. Stahl","orcid":"https://orcid.org/0000-0002-6536-6973","observed_orcids":["https://orcid.org/0000-0002-6536-6973"]},"institutions":[{"id":"https://openalex.org/I4210146149","display_name":"Neuroscience Education Institute","ror":"https://ror.org/058c0g260","country_code":"US","type":"other","lineage":["https://openalex.org/I4210146149"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen M. Stahl","raw_affiliation_strings":["Neuroscience Education Institute, 1930 Palomar Point Way, Carlsbad, CA 92008, USA. smstahl@neiglobal.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Education Institute, 1930 Palomar Point Way, Carlsbad, CA 92008, USA. smstahl@neiglobal.com","institution_ids":["https://openalex.org/I4210146149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001872837","display_name":"Clara Lee-Zimmerman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Clara Lee-Zimmerman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Sylvia Cartwright","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sylvia Cartwright","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5058547941","display_name":"Debbi Ann Morrissette","orcid":"https://orcid.org/0000-0002-2866-7929","observed_orcids":["https://orcid.org/0000-0002-2866-7929"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Debbi Ann Morrissette","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":12.0375,"has_fulltext":false,"cited_by_count":273,"citation_normalized_percentile":{"value":0.99506531,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"14","issue":"5","first_page":"578","last_page":"585"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/serotonergic-antidepressants","display_name":"serotonergic antidepressants","score":0.8050000071525574},{"id":"https://openalex.org/keywords/serotonin-transporter-inhibition","display_name":"serotonin transporter inhibition","score":0.9079999923706055},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.656000018119812},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9729999899864197},{"id":"https://openalex.org/keywords/serotonin-norepinephrine-reuptake-inhibitors","display_name":"serotonin-norepinephrine reuptake inhibitors","score":0.9330000281333923},{"id":"https://openalex.org/keywords/bupropion","display_name":"bupropion","score":0.8069999814033508},{"id":"https://openalex.org/keywords/trazodone","display_name":"trazodone","score":0.9810000061988831},{"id":"https://openalex.org/keywords/mirtazapine","display_name":"mirtazapine","score":1.0},{"id":"https://openalex.org/keywords/buspirone","display_name":"buspirone","score":0.9959999918937683},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8820000290870667},{"id":"https://openalex.org/keywords/vilazodone","display_name":"vilazodone","score":0.9010000228881836},{"id":"https://openalex.org/keywords/vortioxetine","display_name":"vortioxetine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/multimodal-antidepressant","display_name":"multimodal antidepressant","score":0.8159999847412109},{"id":"https://openalex.org/keywords/sexual-dysfunction","display_name":"sexual dysfunction","score":0.49300000071525574},{"id":"https://openalex.org/keywords/antidepressant-side-effects","display_name":"antidepressant side effects","score":0.7760000228881836}],"concepts":[{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.6534172296524048},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.6516894102096558},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6258991360664368},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.5978977084159851},{"id":"https://openalex.org/C2777287423","wikidata":"https://www.wikidata.org/wiki/Q412194","display_name":"Buspirone","level":4,"score":0.5412847399711609},{"id":"https://openalex.org/C99631742","wikidata":"https://www.wikidata.org/wiki/Q22290476","display_name":"Reuptake","level":4,"score":0.5315316319465637},{"id":"https://openalex.org/C2779908668","wikidata":"https://www.wikidata.org/wiki/Q834280","display_name":"Bupropion","level":3,"score":0.5083195567131042},{"id":"https://openalex.org/C2908747647","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"Serotonin Plasma Membrane Transport Proteins","level":5,"score":0.47380322217941284},{"id":"https://openalex.org/C2778897192","wikidata":"https://www.wikidata.org/wiki/Q410142","display_name":"Serotonin transporter","level":4,"score":0.45059192180633545},{"id":"https://openalex.org/C176233148","wikidata":"https://www.wikidata.org/wiki/Q14874257","display_name":"Norepinephrine transporter","level":4,"score":0.44770553708076477},{"id":"https://openalex.org/C126855140","wikidata":"https://www.wikidata.org/wiki/Q14891424","display_name":"5-HT2A receptor","level":5,"score":0.4289158582687378},{"id":"https://openalex.org/C2781068410","wikidata":"https://www.wikidata.org/wiki/Q421930","display_name":"Mirtazapine","level":4,"score":0.4256761074066162},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4256387948989868},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.3985918462276459},{"id":"https://openalex.org/C53910766","wikidata":"https://www.wikidata.org/wiki/Q238516","display_name":"5-HT receptor","level":4,"score":0.33743441104888916},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.3004075288772583},{"id":"https://openalex.org/C2778514916","wikidata":"https://www.wikidata.org/wiki/Q186242","display_name":"Norepinephrine","level":3,"score":0.27996379137039185},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2508133053779602},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.15739518404006958},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C2777843972","wikidata":"https://www.wikidata.org/wiki/Q2462253","display_name":"Smoking cessation","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012701","descriptor_name":"Serotonin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D050486","descriptor_name":"Serotonin Plasma Membrane Transport Proteins","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D050486","descriptor_name":"Serotonin Plasma Membrane Transport Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D054333","descriptor_name":"Drug Partial Agonism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/1389450111314050007","doi":"https://doi.org/10.2174/1389450111314050007","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1389450111314050007","pdf_url":null,"source":{"id":"https://openalex.org/S140884253","display_name":"Current Drug Targets","issn_l":"1389-4501","issn":["1389-4501","1873-5592"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Drug Targets","raw_type":"journal-article"},{"id":"pmid:23531115","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23531115","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current drug targets","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":62,"referenced_works":["https://openalex.org/W88308917","https://openalex.org/W165868506","https://openalex.org/W1481467619","https://openalex.org/W1577063440","https://openalex.org/W1623415077","https://openalex.org/W1680855902","https://openalex.org/W1709672860","https://openalex.org/W1840650665","https://openalex.org/W1933676799","https://openalex.org/W1970755410","https://openalex.org/W1981648956","https://openalex.org/W1981679498","https://openalex.org/W1987514922","https://openalex.org/W1990663756","https://openalex.org/W2000247455","https://openalex.org/W2000941955","https://openalex.org/W2001108200","https://openalex.org/W2002519594","https://openalex.org/W2003732657","https://openalex.org/W2013158932","https://openalex.org/W2016437478","https://openalex.org/W2019578958","https://openalex.org/W2024212656","https://openalex.org/W2029145502","https://openalex.org/W2029732660","https://openalex.org/W2031385069","https://openalex.org/W2033285012","https://openalex.org/W2033948826","https://openalex.org/W2035989141","https://openalex.org/W2037633842","https://openalex.org/W2044633079","https://openalex.org/W2044827759","https://openalex.org/W2046233567","https://openalex.org/W2048229331","https://openalex.org/W2049177233","https://openalex.org/W2049291904","https://openalex.org/W2054766240","https://openalex.org/W2055102381","https://openalex.org/W2067382805","https://openalex.org/W2069376128","https://openalex.org/W2069768395","https://openalex.org/W2073374285","https://openalex.org/W2077517185","https://openalex.org/W2077534611","https://openalex.org/W2082406742","https://openalex.org/W2091159680","https://openalex.org/W2092683487","https://openalex.org/W2097053175","https://openalex.org/W2101161401","https://openalex.org/W2102480288","https://openalex.org/W2103101288","https://openalex.org/W2111977644","https://openalex.org/W2127082049","https://openalex.org/W2129633806","https://openalex.org/W2132324173","https://openalex.org/W2141083688","https://openalex.org/W2142917176","https://openalex.org/W2156782268","https://openalex.org/W2163267194","https://openalex.org/W2164650786","https://openalex.org/W2606237774","https://openalex.org/W4360754754"],"related_works":["https://openalex.org/W2002937405","https://openalex.org/W2735127571","https://openalex.org/W3082764919","https://openalex.org/W2028306465","https://openalex.org/W2339700702","https://openalex.org/W3194328776","https://openalex.org/W2340106706","https://openalex.org/W1564542996","https://openalex.org/W2129140710","https://openalex.org/W1986988181"],"abstract_inverted_index":{"The":[0,14],"current":[1],"generation":[2],"of":[3,62,199],"antidepressant":[4,147],"drugs":[5,46,101],"acts":[6],"predominantly":[7],"by":[8,44,55,206],"targeting":[9,200],"the":[10,118,151,165,174,197],"serotonin":[11,26,50],"transporter":[12,176],"(SERT).":[13],"original":[15],"trend":[16],"to":[17,32,114,194],"do":[18],"this":[19],"selectively":[20],"(e.g.,":[21,47,66],"with":[22,38,58,68,75,79,87,94,128,140],"SSRIs":[23,57],"or":[24,49,54,83],"selective":[25],"reuptake":[27,52,72,132,138],"inhibitors)":[28],"has":[29],"given":[30],"way":[31],"combining":[33,148],"various":[34,181],"additional":[35],"pharmacologic":[36,110],"mechanisms":[37,111],"SERT":[39,115,129,141,186,207],"inhibition,":[40],"including":[41,196],"dual":[42],"actions":[43,149],"single":[45],"SNRIs":[48],"norepinephrine":[51,71,135],"inhibitors),":[53],"augmenting":[56],"a":[59,63,145],"second":[60],"drug":[61],"different":[64],"mechanism":[65],"bupropion":[67],"dopamine":[69,137],"and":[70,97,136,143,157,161,210],"inhibition;":[73],"trazodone":[74],"5HT2A":[76],"antagonism;":[77,81],"mirtazapine":[78],"5HT2A/5HT2C/5HT3/alpha2":[80],"buspirone":[82],"some":[84],"atypical":[85,92],"antipsychotics":[86,93],"5HT1A":[88,125],"partial":[89,126,159],"agonism;":[90],"other":[91,98],"5HT2C/5HT7":[95],"antagonism":[96],"mechanisms).":[99],"Novel":[100],"in":[102,112],"development":[103],"include":[104],"those":[105],"that":[106,183],"combine":[107],"multiple":[108],"simultaneous":[109],"addition":[113],"inhibition":[116,139,187,208],"within":[117],"same":[119],"molecule,":[120],"such":[121,214],"as":[122,171,173,215],"vilazodone":[123],"(combining":[124,134],"agonism":[127,160],"inhibition),":[130,142],"triple":[131],"inhibitors":[133],"vortioxetine,":[144],"multimodal":[146],"at":[150,164],"G":[152],"protein":[153],"receptor":[154],"mode":[155,168,177],"(5HT1A":[156],"5HT1B":[158],"5HT7":[162],"antagonism),":[163],"ion":[166],"channel":[167],"(5HT3":[169],"antagonism)":[170],"well":[172,204],"neurotransmitter":[175],"(SERT":[178],"inhibition).":[179],"These":[180],"strategies":[182],"build":[184],"upon":[185],"provide":[188],"promise":[189],"for":[190],"novel":[191],"therapeutic":[192],"approaches":[193],"depression,":[195],"possibility":[198],"residual":[201],"symptoms":[202],"not":[203],"treated":[205],"alone,":[209],"reducing":[211],"side":[212],"effects,":[213],"sexual":[216],"dysfunction.":[217]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":165},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":16},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":20},{"year":2013,"cited_by_count":6}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}